8,452 Call Contracts on Divis Laboratories Ltd Signal Strong Near-Term Upside

1 hour ago
share
Share Via
On 8 September 2026, Divis Laboratories Ltd witnessed robust call option activity with 8,452 contracts traded at the Rs 9,400 strike price. The stock closed at Rs 9,443.50, just above the strike, reflecting a close alignment between the derivatives and cash markets as the share price edged 1.62% higher on the day.
8,452 Call Contracts on Divis Laboratories Ltd Signal Strong Near-Term Upside

Options Event and Cash Market Price Action

The call options expiring on 29 September 2026 attracted significant attention, with turnover reaching approximately ₹1,625 lakhs. The strike price of Rs 9,400 sits almost exactly at-the-money relative to the underlying price of Rs 9,443.50, indicating that traders are positioning for immediate directional movement rather than a distant target. The open interest at this strike stands at 1,625 contracts, nearly matching the day's traded volume, which suggests a substantial influx of fresh positions rather than mere rollovers or position adjustments. This is further underscored by the contracts-to-open interest ratio of roughly 5.2:1, a level that points to active new money entering the call options market.

The stock has been on a positive trajectory, gaining 3.67% over the past two sessions and outperforming its sector by 1.19% on the day. This momentum in the cash market is mirrored by the surge in call option activity, signalling a convergence of sentiment across both markets — does this alignment suggest a sustained directional conviction or a short-term tactical move?

Strike Price and Moneyness Analysis

The Rs 9,400 strike price is effectively at-the-money given the underlying's close proximity at Rs 9,443.50. At-the-money calls are the most sensitive to price changes in the underlying stock, exhibiting high gamma, which means that even small movements in the stock price can significantly affect the option's value. This strike selection reveals that market participants are betting on near-term price action rather than speculative upside far above the current level. The expiry date, just three weeks away, adds urgency to this positioning, indicating a short-term directional bet rather than a long-term hedge or speculative play.

Such at-the-money call activity often reflects confidence in a continuation of the current trend or a breakout from a consolidation phase. The stock's proximity to its 52-week high of Rs 9,467 (just 0.35% away) further supports the notion that traders are eyeing a potential push beyond recent resistance levels — is this a signal of imminent breakout or a pause before a reversal?

Open Interest and Contracts Analysis

Open interest at the Rs 9,400 strike stands at 1,625 contracts, closely matching the 8,452 contracts traded on the day. This high turnover relative to open interest suggests a significant amount of fresh positioning, as opposed to existing holders merely adjusting their exposure. The contracts-to-OI ratio of approximately 5.2:1 is indicative of aggressive new money entering the market, which often precedes notable price moves in the underlying stock.

Moreover, the open interest level itself is substantial, signalling that this strike price is a focal point for market participants. The combination of high open interest and heavy trading volume at this strike suggests that the Rs 9,400 level is a key battleground for directional bets in Divis Laboratories Ltd options — does this concentration of activity foreshadow a decisive move or increased volatility ahead of expiry?

Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!

  • - Complete fundamentals package
  • - Technical momentum confirmed
  • - Reasonable valuation entry

Add to Your Radar Now →

Cash Market Context: Momentum and Moving Averages

Divis Laboratories Ltd is trading comfortably above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages — signalling a strong uptrend. The stock's recent gains of 3.67% over two sessions and a 1.62% rise on 8 September reinforce this momentum. The narrow trading range of just Rs 2.5 on the day suggests controlled, steady buying rather than erratic swings.

Such technical strength aligns well with the at-the-money call activity, which is typically a bet on continued upward movement in the near term. The stock's proximity to its 52-week high further adds to the narrative of a potential breakout, with the options market seemingly echoing this sentiment — is the technical setup robust enough to sustain this rally or is a pullback imminent?

Delivery Volume and Liquidity Considerations

Despite the strong price gains and call option activity, delivery volumes on 7 September fell by 2.89% compared to the 5-day average, with 3.23 lakh shares delivered. This slight decline in investor participation in the cash market contrasts with the surge in derivatives activity, suggesting that the bullish conviction is currently more pronounced in the options segment than in outright stock buying.

However, the stock remains sufficiently liquid, with a trade size capacity of approximately ₹8.58 crores based on 2% of the 5-day average traded value. This liquidity supports active trading and reduces the risk of price distortions due to thin volumes. The divergence between falling delivery volumes and rising call activity raises the question of whether the options market is anticipating a move ahead of the cash market — is this a leading indicator or a sign of cautious cash market participants?

Want to dive deeper on Divis Laboratories Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Key Data at a Glance

Underlying Price
₹9,443.50
Strike Price
₹9,400
Contracts Traded
8,452
Open Interest
1,625
Turnover
₹1,624.98 lakhs
Expiry Date
29 Sep 2026
Price Change (1D)
+1.62%
52-Week High Proximity
0.35% below

Conclusion: What the Options and Cash Data Collectively Signal

The heavy call option activity at the Rs 9,400 strike price, combined with the stock trading just above this level, points to a focused near-term directional bet on Divis Laboratories Ltd. The high contracts-to-open interest ratio indicates fresh money entering the market, while the proximity to the 52-week high and strong technical positioning reinforce the bullish undertone.

However, the slight decline in delivery volumes amid rising call activity introduces a subtle note of caution, suggesting that the derivatives market may be anticipating moves that the cash market has yet to fully embrace. The stock’s position above all major moving averages supports the current momentum, but the narrow trading range hints at a potential pause or consolidation.

With just three weeks until expiry, the urgency behind these at-the-money calls is clear — is this a momentum play worth following or a tactical bet that requires close monitoring?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News